Table 1. ALDH2 activity and infarct size in hearts subjected to ischemia and reperfusion, ex vivo.

The experimental details are provided in SOM (5) and in Figure 1.

Treatment	ALDH2 activity (μ molNADH/min/mg protein)	Infarct size (%)	n
Normoxia	2.5±0.1	5±4	3
Nor + Cya	0.9±0.1#	7±5	3
Ischemia	2.4±0.2	45±6	5
Isc + EtOH	2.9±0.1*	33±10*	5
Isc + ψεR	3.2±0.1*	23±10**	5
Isc + εV1-2 + EtOH	2.4±0.3	42±5	5
Isc + Cya	0.9±0.1**	67±9**	5
Isc + Cya + EtOH	0.9±0.1**	73±8**	5
Isc + Cya + ψεR	0.6±0.1**	70±7**	5
Isc + GTN	1.7±0.1**	59±8*	8
Isc+ GTN + EtOH	1.5±0.1**	63±9*	8
Isc+ GTN + ψεR	1.5±0.1**	61±6*	8
Isc + SNP	2.3±0.1	45±7	8
Isc +GTN off	2.1±0.2	33±8*	5
Isc + GTN on	1.5±0.1*	59±7*	5

^#p<0.01 from normoxia

^*p<0.01

^**p<0.05 from ischemia